Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Brechner or one of our nurse practitioners
10.1093/brain/awz414 152 QianD.XuJ.ZhangX.HuF.CaoS.DongY.et al (2024)
In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension
Metabolic syndrome: updates on pathophysiology and management in 2021
US$ 22.00
US$ 22.90
US$ 26.47
US$ 24.14
US$ 21.31
